If binocular vision is good, the brain mechanism of motor fusion, which aligns the eyes on a target visible to both, can stabilize the corrected alignment.In January 2014, botulinum toxin was approved by UKs Medicines and Healthcare products Regulatory Agency for treatment of restricted ankle motion due to lower-limb spasticity associated with stroke in adults.On 29 July 2016, the U.S. Food and Drug Administration (FDA) approved abobotulinumtoxinA for injection for the treatment of lower-limb spasticity in pediatric patients two years of age and older. AbobotulinumtoxinA is the first and only FDA-approved botulinum toxin for the treatment of pediatric lower limb spasticity. In the U.S., the FDA approves the text of the labels of prescription medicines and for which medical conditions the drug manufacturer may sell the drug. However, prescribers may freely prescribe them for any condition they wish, also known as off-label use. Botulinum toxins have been used off-label for several pediatric conditions, including infantile esotropia. Excessive sweating
AbobotulinumtoxinA (BTX-A) has been approved for the treatment of excessive underarm sweating of unknown cause, which cannot be managed by topical agents. Migraine
In 2010, the FDA approved intramuscular botulinum toxin injections for prophylactic treatment of chronic migraine headache. Cosmetic Indications
In cosmetic applications, botulinum toxin is considered relatively safe and effective for reduction of facial wrinkles, especially in the uppermost third of the face. Commercial forms are marketed under the brand names Botox Cosmetic/Vistabel from Allergan, Dysport/Azzalure from Galderma and Ipsen, Xeomin/Bocouture from Merz, Jeuveau/Nuceiva from Evolus, manufactured by Daewoong in South Korea.
Pathological specimens to be obtained for investigations include:

Sputum for culture, AAFBS and gram stain
Blood for full hemogram/complete blood count, ESR and other acute phase reactants
Procalcitonin test, more specificOn a posteroanterior and lateral chest radiograph, an entire lobe will be radiopaque, which is indicative of lobar pneumonia. The identification of the infectious organism (or other cause) is an important part of modern treatment of pneumonia. The anatomical patterns of distribution can be associated with certain organisms, and can help in selection of an antibiotic while waiting for the pathogen to be cultured. References
External links
 Media related to Lobar pneumonia at Wikimedia Commons